4//SEC Filing
Boyd Thomas A 4
Accession 0001441844-10-000052
CIK 0000835887other
Filed
Jul 5, 8:00 PM ET
Accepted
Jul 6, 2:16 PM ET
Size
15.8 KB
Accession
0001441844-10-000052
Insider Transaction Report
Form 4
Boyd Thomas A
Sr. VP, Product Dev.
Transactions
- Tax Payment
Common Stock
2010-07-01$5.35/sh−2,402$12,851→ 37,137 total - Exercise/Conversion
Common Stock
2010-07-01$4.44/sh+2,675$11,877→ 39,539 total - Award
Common Stock
2010-07-01+10,000→ 47,137 total - Award
ESPP (right to buy)
2010-07-01+2,299→ 2,299 totalExercise: $5.48From: 2011-01-01Exp: 2011-01-01→ Common Stock (2,299 underlying) - Exercise/Conversion
ESPP (right to buy)
2010-07-01−2,675→ 0 totalExercise: $4.44From: 2010-07-01Exp: 2010-07-01→ Common Stock (2,675 underlying) - Award
Non-Qualified Stock Option (right to buy)
2010-07-01+30,000→ 30,000 totalExercise: $5.35From: 2011-07-01Exp: 2020-07-01→ Common Stock (30,000 underlying)
Footnotes (7)
- [F1]Acquired upon the complete exercise of a grant under the Non-Qualified Employee Stock Purchase Plan, which grant was previously reported at the start of a six month option term, to acquire common stock up to an option amount which is 25% of the optionee's quarterly salary less $6,250, at a purchase price equal to the lower of 100% of the market value on the date of grant or 85% of the market value on the date of exercise.
- [F2]Includes shares of common stock acquired from the non-reportable exercise under a Qualified Employee Stock Purchase Plan.
- [F3]Restricted Stock shall vest in three equal installments, commencing June 20, 2010.
- [F4]Granted under the Company's Non-Qualified Employeee Stock Purchase Plan.
- [F5]The option was granted on the first day of the option term and previously reported as a right to purchase shares of the Company's common stock at an exercise price equal to the market value on the date of grant. In accordance with the Non-Qualified Employee Stock Purchase Plan, the option is ultimately exercisable for an exercise price which is the lower of 100% of the market value on the grant date or 85% of the market value on the day prior to the exercise date. The number of shares exercised is based on the option amount divided by the lower of 100% of the market value on the grant date or 85% of the market value on the day prior to the exercise date.
- [F6]The option will be exercisable for that number of shares equal to the option amount (25% of the optionee's quarterly salary less $6,250) divided by the lesser of the market value of the common stock on the grant date or 85% of the market value on the day prior to the exercise date.
- [F7]The stock options become exercisable in three equal installments, commencing one year from the grant date.
Documents
Issuer
PROGENICS PHARMACEUTICALS INC
CIK 0000835887
Entity typeother
Related Parties
1- filerCIK 0001327433
Filing Metadata
- Form type
- 4
- Filed
- Jul 5, 8:00 PM ET
- Accepted
- Jul 6, 2:16 PM ET
- Size
- 15.8 KB